/Cooper%20Companies%2C%20Inc_%20building%20logo-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Valued at a market cap of $19.5 billion, The Cooper Companies, Inc. (COO) is a specialty medical device company that primarily develops, manufactures, and markets contact lens wearers. The San Ramon, California-based company also sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. It is expected to announce its fiscal Q1 earnings results after the market closes on Thursday, Mar. 6.
Ahead of this event, analysts project the medical device company to report a profit of $0.92 per share, up 8.2% from $0.85 per share in the year-ago quarter. The company has a promising trajectory of consistently beating Wall Street's bottom-line estimates in the last four quarters. In Q4 2024, COO’s EPS of $1.04 outpaced the forecasted figure by a notable margin of 4%.
